# Trifecta Research Study

> **NCT07717866** · — · ACTIVE_NOT_RECRUITING · sponsor: **Axial Therapeutic Research** · enrollment: 52 (actual)

## Conditions studied

- PTSD - Post Traumatic Stress Disorder
- Cognitive Dysfunction
- Brain Injury
- Depression - Major Depressive Disorder
- Suicidal Ideation

## Interventions

- **DEVICE:** Magnetic e-Resonance Therapy (MeRT)
- **DRUG:** Ibogaine Hydrochloride with Magnesium Sulfate
- **DRUG:** 5-methoxy-N,N-dimethyltryptamine
- **DRUG:** Physiological Supplementation

## Key facts

- **NCT ID:** NCT07717866
- **Lead sponsor:** Axial Therapeutic Research
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-01
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-11
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07717866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07717866, "Trifecta Research Study". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07717866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*